Approved: New HIV Med Entravine

Johnson & Johnson's HIV drug, entravine, was approved by the FDA on Friday. As mentioned here in July, the medication has proven to be very effective against advanced multi-drug resistant HIV. Entravine is an NNRTI (non-nucleoside reverse transriptase inhibitor) and must be taken in combination with other anti-HIV medications.

The drug was approved under the fast-track or "priority review" status that the FDA reserves for medications meant to treat life-threatening disease. No word yet as to what name entravine will be sold under. Considering the recent run of HIV med names (Kaletra, Truvada), I wouldn't care to guess.